.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the state of New York, Chime & Chill has shown a consistent presence in the Tincture & Sublingual category, maintaining a 10th place ranking for both January and February 2025. This stability in ranking is accompanied by a noticeable increase in sales from January to February, indicating a positive reception in the market. However, the absence of rankings for March and April suggests that Chime & Chill may have fallen out of the top 30 brands in this category during those months, which could be an area of concern or a potential opportunity for improvement.
Conversely, in the Topical category within New York, Chime & Chill has consistently held the 3rd place ranking from February through April 2025, demonstrating strong performance and market presence. Despite a slight dip in sales from March to April, the brand's ability to maintain such a high ranking suggests robust consumer demand and effective market positioning. The consistent top-tier ranking in this category highlights Chime & Chill's strength and potential for growth, especially if they can address the sales fluctuation observed in the latest month.
Competitive Landscape
In the competitive landscape of the New York topical cannabis market, Chime & Chill has shown a consistent performance, maintaining its position as the third-ranked brand from February to April 2025. Despite not being in the top 20 in January, Chime & Chill quickly gained traction, indicating a positive growth trajectory. The brand is trailing behind Ayrloom, the market leader that has consistently held the top spot, and Veterans Choice Creations (VCC), which has maintained its second-place position. While Ayrloom's sales figures are significantly higher, Chime & Chill's steady rank suggests a solidifying presence in the market. This upward trend highlights the brand's potential to capture more market share if it continues to leverage its growth momentum effectively.
Notable Products
In April 2025, the top-performing product from Chime & Chill was the CBD/CBN 2:1 PM Lotion (300mg CBD, 150mg CBN) in the Topical category, maintaining its number one rank from March despite a slight decrease in sales to 189 units. Following closely, the CBD Tincture K.O. Double Dose (4500mg CBD, 30ml) held steady in second place within the Tincture & Sublingual category, though it experienced a consistent drop in sales from February's peak of 204 units to 117 in April. The CBD/CBG 2:1 AM Body Cream (300mg CBD, 150mg CBG) remained third, showing a slight recovery in sales compared to previous months. The CBD/CBN 2:1 PM Oral Solution 10-Pack (200mg CBD, 100mg CBN) consistently ranked fourth, with a slight increase in sales to 70 units. Notably, the CBD/THC Calm & Chill PM Bath Salts (100mg CBD, 100mg THC) re-entered the rankings in fifth place, improving from February with 61 units sold in April.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
